News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
565,302 Results
Type
Article (33575)
Company Profile (157)
Press Release (531562)
Multimedia
Podcasts (102)
Webinars (14)
Section
Business (167193)
Career Advice (1475)
Deals (29794)
Drug Delivery (104)
Drug Development (63940)
Employer Resources (111)
FDA (12099)
Job Trends (12062)
News (280203)
Policy (27164)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2246)
Academic (1)
Accelerated approval (25)
Adcomms (20)
Allergies (109)
Alliances (41383)
ALS (130)
Alzheimer's disease (1213)
Antibody-drug conjugate (ADC) (220)
Approvals (12375)
Artificial intelligence (370)
Autoimmune disease (109)
Automation (24)
Bankruptcy (261)
Best Places to Work (9152)
BIOSECURE Act (21)
Biosimilars (166)
Biotechnology (75)
Bladder cancer (100)
Brain cancer (48)
Breast cancer (444)
Cancer (3411)
Cardiovascular disease (311)
Career advice (1266)
Career pathing (24)
CAR-T (169)
CDC (43)
Celiac Disease (1)
Cell therapy (466)
Cervical cancer (33)
Clinical research (55052)
Collaboration (1272)
Company closure (1)
Compensation (652)
Complete response letters (48)
COVID-19 (2268)
CRISPR (69)
C-suite (734)
Cystic fibrosis (112)
Data (4484)
Decentralized trials (1)
Denatured (29)
Depression (103)
Diabetes (350)
Diagnostics (4861)
Digital health (36)
Diversity (8)
Diversity, equity & inclusion (32)
Drug discovery (179)
Drug pricing (172)
Drug shortages (29)
Duchenne muscular dystrophy (159)
Earnings (68991)
Editorial (46)
Employer branding (14)
Employer resources (102)
Events (85808)
Executive appointments (869)
FDA (14363)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (8)
Frontotemporal dementia (16)
Funding (1098)
Gene editing (126)
Generative AI (32)
Gene therapy (410)
GLP-1 (766)
Government (4004)
Grass and pollen (6)
Guidances (327)
Healthcare (14261)
HIV (54)
Huntington's disease (27)
IgA nephropathy (67)
Immunology and inflammation (169)
Immuno-oncology (43)
Indications (88)
Infectious disease (2462)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (77)
Intellectual property (171)
Interviews (230)
IPO (13210)
IRA (43)
Job creations (3214)
Job search strategy (1101)
JPM (51)
Kidney cancer (14)
Labor market (54)
Layoffs (372)
Leadership (25)
Legal (6709)
Liver cancer (63)
Longevity (12)
Lung cancer (479)
Lymphoma (276)
Machine learning (24)
Management (41)
Manufacturing (631)
MASH (140)
Medical device (8472)
Medtech (8506)
Mergers & acquisitions (17414)
Metabolic disorders (941)
Multiple sclerosis (131)
NASH (21)
Neurodegenerative disease (209)
Neuropsychiatric disorders (60)
Neuroscience (2125)
Neurotech (1)
NextGen: Class of 2026 (5171)
Non-profit (3940)
Now hiring (31)
Obesity (439)
Opinion (211)
Ovarian cancer (96)
Pain (171)
Pancreatic cancer (136)
Parkinson's disease (181)
Partnered (29)
Patents (335)
Patient recruitment (324)
Peanut (31)
People (52064)
Pharmaceutical (70)
Pharmacy benefit managers (25)
Phase 1 (15573)
Phase 2 (24032)
Phase 3 (19573)
Pipeline (4218)
Policy (256)
Postmarket research (2127)
Preclinical (6320)
Press Release (72)
Prostate cancer (174)
Psychedelics (36)
Radiopharmaceuticals (218)
Rare diseases (667)
Real estate (5126)
Recruiting (42)
Regulatory (19866)
Reports (31)
Research institute (2080)
Resumes & cover letters (203)
Rett syndrome (24)
RNA editing (10)
RSV (52)
Schizophrenia (123)
Series A (175)
Series B (131)
Service/supplier (6)
Sickle cell disease (70)
Special edition (14)
Spinal muscular atrophy (126)
Sponsored (27)
Startups (2886)
State (2)
Stomach cancer (11)
Supply chain (78)
Tariffs (86)
The Weekly (71)
Vaccines (766)
Venture capital (66)
Weight loss (286)
Women's health (65)
Worklife (11)
Date
Last 7 days (405)
Last 30 days (1631)
Last 365 days (21812)
2026 (2880)
2025 (22227)
2024 (26051)
2023 (30118)
2022 (40375)
2021 (43734)
2020 (42754)
2019 (37252)
2018 (28392)
2017 (26067)
2016 (25669)
2015 (30476)
2014 (24302)
2013 (20373)
2012 (21794)
2011 (22719)
2010 (20651)
Location
Africa (676)
Alabama (42)
Alaska (5)
Arizona (199)
Arkansas (10)
Asia (39451)
Australia (5275)
California (7571)
Canada (2772)
China (1165)
Colorado (328)
Connecticut (332)
Delaware (224)
Europe (74395)
Florida (1304)
Georgia (241)
Hawaii (1)
Idaho (53)
Illinois (635)
India (66)
Indiana (382)
Iowa (14)
Japan (400)
Kansas (105)
Kentucky (38)
Louisiana (22)
Maine (66)
Maryland (1032)
Massachusetts (5639)
Michigan (217)
Minnesota (419)
Mississippi (4)
Missouri (97)
Montana (21)
Nebraska (21)
Nevada (92)
New Hampshire (40)
New Jersey (2457)
New Mexico (22)
New York (2178)
North Carolina (1081)
North Dakota (5)
Northern California (3688)
Ohio (253)
Oklahoma (15)
Oregon (27)
Pennsylvania (1603)
Puerto Rico (17)
Rhode Island (27)
South America (956)
South Carolina (36)
South Dakota (1)
Southern California (3043)
Tennessee (147)
Texas (1208)
United States (28460)
Utah (202)
Vermont (1)
Virginia (237)
Washington D.C. (62)
Washington State (609)
West Virginia (3)
Wisconsin (108)
Wyoming (2)
565,302 Results for "china national pharmaceutical group corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Obesity
Kailera, Hengrui Push Oral GLP-1/GIP Pill to Phase 3 After Clearing Mid-Stage China Study
Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.
February 10, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Zai Lab Announces Updates to China’s National Reimbursement Drug List
December 8, 2025
·
8 min read
Press Releases
Bausch Health’s Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
December 2, 2025
·
4 min read
Press Releases
HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China
December 8, 2025
·
7 min read
Insights
CRO Boom in APAC Region, With China at the Forefront
The CRO market in the APAC region is thriving, particularly in China, due to intense clinical trial and innovation development, with Western investors and pharma leaning in.
November 19, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 12, 2026
·
3 min read
Press Releases
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
December 10, 2025
·
4 min read
Press Releases
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
January 7, 2026
·
7 min read
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
October 17, 2025
·
2 min read
·
Tristan Manalac
1 of 56,531
Next
